Mike
@mphpink.bsky.social
Dad. Husband. Long Islander. Really freaked out right now.
You give Lecanemab (Leqembi) initially every two weeks (biweekly) for at least 18 months, then can switch to monthly (every four weeks) or weekly subcutaneous dosing, while Donanemab is given monthly (every four weeks) until amyloid plaque is cleared. Not a doctor, just Google info.
December 12, 2025 at 11:09 AM
You give Lecanemab (Leqembi) initially every two weeks (biweekly) for at least 18 months, then can switch to monthly (every four weeks) or weekly subcutaneous dosing, while Donanemab is given monthly (every four weeks) until amyloid plaque is cleared. Not a doctor, just Google info.
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
December 12, 2025 at 3:41 AM
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
December 12, 2025 at 3:41 AM
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
December 12, 2025 at 3:40 AM
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
December 12, 2025 at 3:40 AM
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
December 12, 2025 at 3:39 AM
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
December 12, 2025 at 3:36 AM
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
December 12, 2025 at 3:36 AM
The main dementia drugs given intravenously are the anti-amyloid monoclonal antibodies Lecanemab (Leqembi) and Donanemab (Kisunla), used for early-stage Alzheimer's to clear amyloid plaques, slowing cognitive decline, with Lecanemab given bi-weekly and Donanemab monthly via IV infusion.
Rising and grinding. You nasty.
December 7, 2025 at 2:56 PM
Rising and grinding. You nasty.
Started off with very strong Anchor Man San Diego vibes.
December 3, 2025 at 4:17 AM
Started off with very strong Anchor Man San Diego vibes.
Your comment, not the other thing.
December 3, 2025 at 4:15 AM
Your comment, not the other thing.
Almost woke up my wife with an audible chuckle during some early morning doom scrolling.
September 13, 2025 at 9:13 AM
Almost woke up my wife with an audible chuckle during some early morning doom scrolling.
Silver Soul Patch Badge unlocked.
September 13, 2025 at 9:07 AM
Silver Soul Patch Badge unlocked.
He's a male member, alright.
April 25, 2025 at 2:06 AM
He's a male member, alright.